Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=3	shorter survival	N=3	longer survival	N=0
AGE	Spearman correlation test	N=17	older	N=10	younger	N=7
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=25	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=13	higher stage	N=13	lower stage	N=0
PATHOLOGY N STAGE	Spearman correlation test	N=176	higher stage	N=89	lower stage	N=87
PATHOLOGY M STAGE	Kruskal-Wallis test	N=202	 	 	 	 
GENDER	Wilcoxon test	N=6	male	N=6	female	N=0
HISTOLOGICAL TYPE	Wilcoxon test	N=820	colon mucinous adenocarcinoma	N=820	colon adenocarcinoma	N=0
RADIATIONS RADIATION REGIMENINDICATION	Wilcoxon test	N=0	 	 	 	 
COMPLETENESS OF RESECTION	Kruskal-Wallis test	N=359	 	 	 	 
NUMBER OF LYMPH NODES	Spearman correlation test	N=120	higher number.of.lymph.nodes	N=55	lower number.of.lymph.nodes	N=65
RACE	Kruskal-Wallis test	N=16	 	 	 	 
